News und Analysen
![Aurinia Reports Fourth Quarter and Full Year 2021 Financial Results and Company Updates: https://mms.businesswire.com/media/20191107005278/en/707846/5/Aurinia-logo-web-700px.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeThpRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5d91333dbb55b274fa0400e435af0453aa80c824/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Aurinia-logo-web-700px.jpg?locale=de)
Aurinia Reports Fourth Quarter and Full Year 2021 Financial Results and Company Updates
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today issued its financial results for the fourth quarter and year ended December 31, 2021. Amounts, unless specified otherwise
![Aurinia Pharmaceuticals to Present at the 11th Annual Leerink Global Healthcare Conference: https://mms.businesswire.com/media/20191107005278/en/707846/5/Aurinia-logo-web-700px.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeThpRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5d91333dbb55b274fa0400e435af0453aa80c824/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Aurinia-logo-web-700px.jpg?locale=de)
Aurinia Pharmaceuticals to Present at the 11th Annual Leerink Global Healthcare Conference
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that the company will deliver a corporate presentation at the 11th Annual Leerink Global Healthcare Conference (February
![Aurinia Pharmaceuticals to Present at Upcoming January Investor Conferences: https://mms.businesswire.com/media/20191107005278/en/707846/5/Aurinia-logo-web-700px.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeThpRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5d91333dbb55b274fa0400e435af0453aa80c824/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Aurinia-logo-web-700px.jpg?locale=de)
Aurinia Pharmaceuticals to Present at Upcoming January Investor Conferences
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that members of the management team will participate in two upcoming virtual investor conferences.
-
H.C. Wainwright
![Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN): https://mms.businesswire.com/media/20191107005278/en/707846/5/Aurinia-logo-web-700px.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeThpRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5d91333dbb55b274fa0400e435af0453aa80c824/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Aurinia-logo-web-700px.jpg?locale=de)
Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN)
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, today announced
![Shockwave Medical Gets 10% Jolt, Leads Medical Gear Makers Higher: https://www.marketbeat.com/logos/articles/med_20230412102502_shockwave-medical-gets-10-jolt-leads-medical-gear.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN1hzYWc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--cc7deefdf3f51d54de5b5b554d59e99a03cf6023/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230412102502_shockwave-medical-gets-10-jolt-leads-medical-gear.jpg?locale=de)
Shockwave Medical Gets 10% Jolt, Leads Medical Gear Makers Higher
The old saying, “I’m from the government, I’m here to help,” is always intended as a punchline, but a Medicare rule changes sure did help shares of Shockwave Medical Inc. (NASDAQ: SWAV).
Shares
![Tilray Brands Consolidates Hold: Profits Will Drive Shares Higher: https://www.marketbeat.com/logos/articles/med_20230411111847_chart-tlry-4112023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMjNzYWc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5b874806835c1804583941f90cdf2baf500fa84e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230411111847_chart-tlry-4112023.png?locale=de)
Tilray Brands Consolidates Hold: Profits Will Drive Shares Higher
Tilray Brands (NASDAQ: TLRY) reported a mixed quarter and a deal to acquire HEXO that sent the market moving lower. While the news is less than spectacular, there are some takeaways for
![Residential Prices, Rents Dip Across Qatar As World Cup Boost Dissipates: https://www.valuewalk.com/wp-content/uploads/2023/08/Rental-Rate-1.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNXhxYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9a8176e7a5718cc499381ff1aace12fa16a2ec0a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Rental-Rate-1.jpg?locale=de)
Residential Prices, Rents Dip Across Qatar As World Cup Boost Dissipates
Residential market declines amid supply surge, office market faces oversupply challenges, retail market competes with increasing pressure, and hotel occupancy falters despite spike in tourist
![Techtronic Denies Short-Seller Jehoshaphat’s Fraud Allegations in Home Depot Business: https://www.valuewalk.com/wp-content/uploads/2023/02/Home-Depot-Stock-300x150.jpeg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM2N0YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--14f786677c241a5a1909d1c93adc6d6dba7416cc/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Home-Depot-Stock-300x150.jpeg?locale=de)
Techtronic Denies Short-Seller Jehoshaphat’s Fraud Allegations in Home Depot Business
A second missive claiming ‘blemished’ channel misdoings are having little impact on Hong Kong-traded shares
Short-seller Jehoshaphat Research (JR) has accused Techtronic Industries (HKG:0669) of
![Aphria Aktie: So greift Sie jetzt nach den Sternen](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Aphria Aktie: So greift Sie jetzt nach den Sternen
![Canopy Growth-Aktie: Hilfe!](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Canopy Growth-Aktie: Hilfe!
![Aphria-Aktie: So macht Börse richtig Spaß!](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Aphria-Aktie: So macht Börse richtig Spaß!
![Canopy Growth löst Glücksgefühle aus!](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Canopy Growth löst Glücksgefühle aus!
![Geduld der Canopy Growth-Anleger hat sich nicht ausgezahlt!](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Geduld der Canopy Growth-Anleger hat sich nicht ausgezahlt!
![Aphria-Aktie: DAS muss noch lange nichts bedeuten](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Aphria-Aktie: DAS muss noch lange nichts bedeuten
![Aphria Aktie: Ist es denn die Möglichkeit?](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Aphria Aktie: Ist es denn die Möglichkeit?
![Canopy Growth-Aktie: So kann es nicht weitergehen!](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Canopy Growth-Aktie: So kann es nicht weitergehen!
![Aphria-Aktie: Da verbrennt man sich die Finger!](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Aphria-Aktie: Da verbrennt man sich die Finger!
![Endlich lohnt sich Aphria!](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Endlich lohnt sich Aphria!
![Aphria-Aktie: So sollte es sein!](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Aphria-Aktie: So sollte es sein!
![Canopy Growth Aktie: Vorbei, vorbei!](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
Canopy Growth Aktie: Vorbei, vorbei!
![Aphria-Aktie: Das könnte richtig bitter werden!](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Aphria-Aktie: Das könnte richtig bitter werden!
![Canopy Growth Aktie: Darf das wirklich wahr sein?](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Canopy Growth Aktie: Darf das wirklich wahr sein?
![Aphria-Aktie: Kommen hier irgendwann auch wieder bessere Zeiten?](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Aphria-Aktie: Kommen hier irgendwann auch wieder bessere Zeiten?
![Canopy Growth-Aktie: Verbrennen sich Anleger hier die Finger?](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
Canopy Growth-Aktie: Verbrennen sich Anleger hier die Finger?
![Aphria Aktie: Wo soll das noch hinführen?](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)